Home › Breast Cancer › Iowa › Ames
Breast Cancer clinical trials in Ames, IA
4 studies for Breast Cancer are looking for participants at sites in and around Ames (within about 30 miles). Open a study to see who can join and how to contact the study team.
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
RecruitingPhase 2
- Accellacare of McFarland, Ames
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecruitingPhase 3
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA110 studies
- Nashville, TN79 studies
- Los Angeles, CA71 studies
- Edison, NJ69 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX54 studies
Other studies in Ames
- Prostate Cancer7 studies
- Lung Cancer7 studies
- Non-Small Cell Lung Cancer6 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Bladder Cancer4 studies
- Chronic Lymphocytic Leukemia3 studies
- Hypopharyngeal Cancer3 studies
- Laryngeal Cancer3 studies
- Oral Cancer3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.